Biomarker discovery in asthma and COPD by proteomic approaches.

Biomarker discovery in asthma and COPD by proteomic approaches.

Item
http://www.wikidata.org/entity/Q38245908
Current and future biomarkers in allergic asthma.Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?Targeted therapy in severe asthma today: focus on immunoglobulin E.The path to personalized medicine in asthma.Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations.Inflammatory biomarkers for asthma endotyping and consequent personalized therapy.Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA - an observational, 2 phase, patient reported outcomes study.Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma.The management of asthma in the phenotype and biomarker era: The proposal of a new diagnostic-therapeutic model.Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma.
P2860

Biomarker discovery in asthma and COPD by proteomic approaches.

Item
http://www.wikidata.org/entity/Q38245908
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Biomarker discovery in asthma and COPD by proteomic approaches.
@en
type
label
Biomarker discovery in asthma and COPD by proteomic approaches.
@en
prefLabel
Biomarker discovery in asthma and COPD by proteomic approaches.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Biomarker discovery in asthma and COPD by proteomic approaches
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921